Cocrystal Pharma (COCP) P/E (2011 - 2026)
Cocrystal Pharma (COCP) P/E from May 19, 2011 to Jun 3, 2026. The TTM Cocrystal Pharma (COCP) P/E is -1.51. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Cocrystal Pharma (COCP)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.51 | +17.40% |
| 2025 | -1.28 | +9.46% |
| 2024 | -1.17 | +36.89% |
| 2023 | -0.86 | +105.80% |
| 2022 | -0.42 | -90.02% |
| 2021 | -4.17 | -49.29% |
| 2020 | -8.23 | +2157.65% |
| 2019 | -0.36 | -83.28% |
| 2018 | -2.18 | +11.23% |
| 2017 | -1.96 | -94.01% |
| 2016 | -32.74 | +5.37% |
| 2015 | -31.08 | -99.93% |
| 2014 | -47.48K | -34.38% |
| 2013 | -72.35K | -80.31% |
| 2012 | -367.41K | -11.68% |
| 2011 | -416.02K | N/A |
Comparison Cocrystal Pharma (COCP) P/E with competitors
Cocrystal Pharma (COCP) P/E is -1.51.